News
Recent University of Kentucky graduate Elaf Ghoneim was born and raised in Lexington, Kentucky. Her family, originally from Libya, established a tight-knit, community-oriented home that emphasized the importance of service and advocacy.
A new University of Kentucky Markey Cancer Center study highlights the success of the largest-ever quality improvement initiative to focus on the critically important issue of smoking among cancer patients.
The University of Kentucky Sanders-Brown Center on Aging Director Linda Van Eldik, PhD, hopes to shed light on how specific brain cells may contribute to the progression of Alzheimer’s disease, paving the way for potential new therapeutic approaches.
University of Kentucky Markey Cancer Centerresearchers identified a protein that could be key to developing new treatments for triple-negative breast cancer.
On Oct. 8, the UK College of Medicine Department of Radiology hosted its inaugural research showcase.
Xiaoqin Jennifer Wang, MD, MS, associate professor of radiology and vice chair for research within the department, kicked off the event with a brief history of radiology and important clinical discoveries over the years.
Please find below an important message from the UK Environmental Management Department:
William Stoops, PhD, was named the 2024 Researcher of the Year by the Kentucky Psychological Association (KPA) in recognition of his service to psychology and outstanding academic record.
The UK College of Medicine Office of Research 2024 Research Awards recognize faculty and staff who have made outstanding contributions to basic, clinical, and translational research in the College of Medicine. Please join us in congratulating the following awardees:
Early Career Mentoring Award in Basic, Translational, or Clinical Research (Faculty)
Researchers at the University of Kentucky were part of a team that discovered a key protein in the brain that can regulate motivation for reward in mice.
Work by several researchers within the University of Kentucky’s Sanders-Brown Center on Aging was recently published in the prestigious journal Nature Genetics.
When Sean Regnier, PhD, started working with people with intellectual and development disabilities (IDD) 10 years ago, he noticed a high rate of cigarette smoking among his clients.
“From a clinical standpoint, I was interested in figuring out how I could help my clients quit smoking,” he said.
Results from a new University of Kentucky Markey Cancer Center study show that molecular tumor boards can play an important role in identifying potential inherited cancer risks, leading to better patient care.
Just like the rest of the human body, the brain changes as it ages. Most people eventually notice some slowed thinking and occasional memory problems. However, serious memory loss, confusion and other major changes in the way the mind works could be a troubling sign that brain cells are failing.
Fourteen University of Kentucky students spent the summer expanding their research skills through the Commonwealth Undergraduate Research Experience (CURE) Fellowship program, sponsored by the Office of Undergraduate Research and the
Cardiovascular disease is a pressing health challenge in Kentucky. It’s one the University of Kentucky and the American Heart Association (AHA) have been working to address for decades.
Since 1949, the AHA has provided more than $41 million through 469 research grants to the University of Kentucky, with 15 grants totaling more than $3.2 million currently active.
In August 2020, the University of Kentucky College of Medicine Office of Research launched 18 Alliance Research Initiative teams from each of the five research priority areas — substance use disorder, cardiovascular, diabetes and obesity, neuroscience, and can
A group of researchers at the University of Kentucky have found a mechanism that would explain why men develop more aortic aneurysms than women.
A groundbreaking lung cancer screening project co-led by the University of Kentucky Markey Cancer Center and the University of Colorado (CU) Cancer Center is set to expand its reach, thanks to a $6.8 million grant from the Bristol Myers Squibb Foundation, an independent charitable organization.
In the ever-evolving field of Alzheimer’s disease research, the development of disease-modifying therapies has sparked both excitement and debate. While these therapies represent a promising shift in the treatment landscape, questions remain about their clinical benefits, risks and economic impact.
Watch below Part 3 of the "Because We Care" mini-documentary series.